Trial intelligence / Profile preview

Intramuscular Peramivir in Uncomplicated Acute Influenza

NCT00419263Phase 2Completed

Sponsor
BioCryst Pharmaceuticals, Inc.
Start
Jan 2007
Primary completion
Sep 2007
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 2 trial of peramivir in influenza, sponsored by BioCryst Pharmaceuticals, Inc.. Started Jan 2007; status: completed.

02

Drugs

peramivir
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00419263.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00419263.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call